Trial Design Solutions

  1. Cell & Gene Therapy Solutions 9/29/2023

    Your therapy can make all the difference. Together, we’ll unlock its potential.

  2. Early Phase Trials In Australia 9/6/2024

    Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.

  3. Supporting Patients For Better Clinical Trials 5/6/2025

    From our inception, Ergomed has been committed to enhancing the patient journey in clinical trials. Our unique Ergomed CARE™ approach revolutionizes trials by optimizing the patient experience. Designed to address and resolve issues proactively, this comprehensive approach supports and engages all stakeholders, leading to accelerated study start-up, improved patient recruitment and retention, and investigator engagement.

  4. Ophthalmic Clinical Research Services 1/26/2023

    With over 40 clinical trials conducted in the area of ophthalmology, Altasciences combines depth of knowledge and expert capabilities to offer you a full range of early ophthalmic clinical development.

  5. Informed Diversity Action Planning Made Simple 11/26/2024

    Develop effective, data-driven Diversity Action Plans tailored to your specific clinical needs with the help of an expert consulting and analytics team.

  6. Pre-Formulation And Material Sciences 3/3/2022

    Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.

  7. The Problem-Solving, Patient Advocate Team That Every Trial Needs 7/22/2025

    Patient Kindness is a supplemental layer of premium support that offers a more seamless clinical trial experience for patients and caregivers with more complex or nuanced needs.

  8. Bringing Endocrine And Metabolic Disease Treatments To Market 9/20/2023

    Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.

  9. Powering Urologic Research With Exclusive Real-World Data 6/25/2025

    These high-quality, fit-for-purpose data modules are tailored to conditions such as prostate cancer, benign prostatic hyperplasia (BPH), non-muscle invasive bladder cancer (NMIBC), and more.

  10. Selecting The Right Pain Model For Early Phase Analgesic Trials 1/26/2023

    Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.